Neoplasm Metastases
19
3
3
11
Key Insights
Highlights
Success Rate
79% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
15.8%
3 terminated out of 19 trials
78.6%
-8.0% vs benchmark
0%
0 trials in Phase 3/4
18%
2 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 11 completed trials
Clinical Trials (19)
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metas
Prospective Assessment of Quality of Life in Patients Treated by Radiosurgery for Brain Metastases (PRAMECE-1302)
Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI (SERENADE)
Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3)
Cognitive Outcome After Gamma Knife Radiosurgery in Patients With Brain Metastases (CAR-Study A)
Stereotactic Radiotherapy (SRT) Liver (COLD 1)
Safety and Pharmacokinetics of Treating Liver Cancer With Drug-Eluting Beads
Study of RAD001 + AMG479 for Patients With Advanced Solid Tumors
Comparing of Modified Wet Suction Technique and Dry Suction Technique for EUS-FNA of Solid Occupying Lesions
Neurocognition After Gamma Knife Radiosurgery for Multiple Brian Metastases
Oral Piroxicam Versus Buccal Fentanyl in Breakthrough Pain
Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma
A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction
A Study to Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies
Prospective Multi-center, Single Blinded, Randomized, Controlled Trial of EUS-FNB and EUS-FNA on Solid Occupying Lesion
A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies
Evaluate The Toxicity And Feasibility Of Intra-Tumoral Injection
Clinical MR Spectroscopy of Brain Metastases at 1,5T and 3T.